Back to search

Sweden· SE-20081003000017

Enyglid 0,5 mg Tablett

A medicinal product containing repaglinide, registered in Sweden by Krka d.d., Novo mesto.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedEnyglid 0,5 mg TablettATC—REGISTER NO.SE-20081003000017PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Repaglinide
Manufacturer
Krka d.d., Novo mesto
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20081003000017

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Repaglinide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All repaglinide products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
  • Belgium · Repaglinide Eg
  • Bulgaria · Индорин
  • Cyprus · Theroflan
  • Czechia · Vatinid
  • Germany · Repaglinid 1 A Pharma, Repaglinid Abz
  • Denmark · Repaglinid Doc Generici
  • Spain · Repaglinida Alter, Repaglinida Aurovitas
  • Finland · Repaglinid Stada
  • France · Repaglinide Arrow Lab, Repaglinide Biogaran
  • United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
  • Greece · Theroflan
  • Croatia · Reglinid, Repaglinid Pharmas
  • Iceland · Enyglid, Novonorm
  • Italy · Glicam, Repaglinide Aurobindo
  • Liechtenstein · Repaglinide Teva
  • Luxembourg · Repaglinide Eg
  • Latvia · Repaglinide Elvim
  • Malta · Repaglinide Aurobindo
  • Netherlands · Repaglinide Stada
  • Norway · Enyglid, Novonorm
  • Romania · Reneos, Repaglinida Arena
  • Slovenia · Repaglinid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59732683-4c90-4b39-9ef5-affd8eaf77cf
GET /v1/drugs/59732683-4c90-4b39-9ef5-affd8eaf77cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20081003000017",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20081003000017",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/enyglid-epar-product-information_sv.pdf"
}

See everything about repaglinide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.